is tirzepatide or semaglutide better for inflammation vs. Weight Loss Tirzepatide vs semaglutide: which weight
Description
Zepbound (tirzepatide) is an FDA-approved medication for chronic weight management that works by activating GIP and GLP-1 receptors to reduce appetite and food intake
The FDA removed tirzepatide from its drug shortage list in October 2024, and a federal court upheld that decision in 2025
Compounded Tirzepatide The most important difference between FDA-approved tirzepatide and the compounded version is the level of oversight
Tirzepatide has shown promising weight loss results in patients who are obese, overweight, and/or have type-2 diabetes
tirzepatide is a dual GIP/GLP-1 agonist) and their side effect profiles differ
It does not need to be elaborate
